1 / 1

Survival Probability Without Infliximab Optimization Over Time

This study analyzes the survival probability percentages associated with a cohort not receiving infliximab optimization. The data visualized in the graph represents survival rates over a period in months and the number of patients at risk at various time points. The findings enhance our understanding of survival dynamics and treatment efficacy in a therapeutic landscape that includes infliximab as a treatment option. The information could inform clinical decisions and future research directions.

duaa
Télécharger la présentation

Survival Probability Without Infliximab Optimization Over Time

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. 100 90 80 70 60 Survival probability without infliximab optimization (%) 50 40 30 20 10 0 0 20 40 60 80 Time (months) Number at risk 80 18 8 3 1 Web Figure 1. Oussalah et al.

More Related